CAMP4 Therapeutics CorporationCAMPNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -47.27% | -47.88% | +60.87% | +27.47% | +3.36% |
| Weighted Average Shares Diluted Growth | -47.27% | -47.88% | +60.87% | +27.47% | +3.36% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -98.45% | +0.00% | +0.00% | -69.28% | -90.43% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -94.13% | +0.00% | +109.63% | +71.24% | +304.40% |
| Book Value per Share Growth | +0.00% | +0.00% | +113.25% | +0.00% | +0.00% |
| Debt Growth | -96.11% | +0.00% | -25.17% | -30.33% | -0.61% |
| R&D Expense Growth | -1.19% | -6.24% | +4.17% | +10.16% | -3.57% |
| SG&A Expenses Growth | +32.94% | +66.61% | +21.59% | +27.77% | +20.50% |